ZFIN ID: ZDB-PUB-131119-21
Multi-dimensional in vivo hazard assessment using zebrafish
Truong, L., Reif, D., St Mary, L., Geier, M., Truong, H.D., and Tanguay, R.L.
Date: 2014
Source: Toxicological sciences : an official journal of the Society of Toxicology 137(1): 212-33 (Journal)
Registered Authors: Tanguay, Robert L.
Keywords: developmental, high-throughput screening, Tox21, ToxCast
MeSH Terms:
  • Animals
  • Cluster Analysis
  • Computational Biology*
  • Dose-Response Relationship, Drug
  • Embryo, Nonmammalian/drug effects
  • Embryo, Nonmammalian/metabolism
  • Embryo, Nonmammalian/pathology
  • Embryonic Development/drug effects
  • Environmental Pollutants/toxicity*
  • High-Throughput Screening Assays*
  • Humans
  • Motor Activity/drug effects
  • Notochord/drug effects
  • Notochord/pathology
  • Reproducibility of Results
  • Risk Assessment
  • Toxicity Tests/methods*
  • Zebrafish/embryology*
PubMed: 24136191 Full text @ Toxicol. Sci.

There are tens of thousands of man-made chemicals in the environment, the inherent safety of most of these chemicals is not known. Relevant biological platforms and new computational tools are needed to prioritize testing of chemicals with limited human health hazard information. We describe an experimental design for high-throughput characterization of multidimensional in vivo effects with the power to evaluate trends relating to commonly-cited chemical predictors. We evaluated all 1,060 unique US EPA ToxCast Phase 1 and 2 compounds using the embryonic zebrafish and found that 487 induced significant adverse biological responses. The utilization of 18 simultaneously measured endpoints means that the entire system serves as a robust biological sensor for chemical hazard. The experimental design enabled us to describe global patterns of variation across tested compounds, evaluate the concordance of the available in vitro and in vivo Phase 1 data with this study, highlight specific mechanisms/value-added/novel biology related to notochord development, and demonstrate that the developmental zebrafish detects adverse responses that would be missed by less comprehensive testing strategies.